Features | Partner Sites | Information | LinkXpress
Sign In
Biostrata Ltd on behalf of Thermo
RANDOX LABORATORIES
FOCUS DIAGNOSTICS, INC.

Recombinant Human Serum Albumin Is Animal-Free

By Labmedica International staff writers
Posted on 15 Dec 2011
A company that develops, manufactures, and markets a portfolio of products used in cell culture, diagnostics, and bioproduction has developed recombinant human serum albumin that is completely animal-free.

Animal-derived media components carry safety concerns involving the risk of viral and prion contamination. As a result, regulatory bodies in the United States, Europe, and Japan have discouraged the use of these components in biomanufacturing. In addition to safety concerns, animal components frequently have high batch-to-batch variation, which leads to unpredictable manufacturing results.

InVitria (Fort Collins, CO, USA) was awarded a USD 725,000 Phase II, Small Business Innovation Research (SBIR) Grant to broaden the applications for InVitria’s recombinant human serum albumin product Cellastim.

The Phase II grant was awarded in 2009 by the National Institutes of Health (NIH; Bethesda, MD, USA) as a two-year project, which was successfully completed on time in 2011. “We are delighted that the objectives of the grant were achieved. The team exceeded those objectives and also implemented current Good Manufacturing Process (cGMP) quality standards for manufacturing recombinant human serum albumin,” said Scott Deeter, president of InVitria.
InVitria is a Division of Ventria Bioscience, the developer of the ExpressTec biomanufacturing system. ExpressTec is the first biomanufacturing system to commercialize recombinant protein manufacturing utilizing plants as the host. InVitria’s product line consists of completely animal-free cell culture media supplements and reagents that are distributed globally by leading distributors in life sciences and cell culture media.

Related Links:
InVitria
National Institutes of Health


EUROIMMUN AG
KARL HECHT GMBH & CO KG
DIASYS DIAGNOSTIC SYSTEMS
WATERS CORPORATION

Channels

Genetic Tests

view channel
Image: The fully automated nCounter Analysis System (Photo courtesy of NanoString Technologies).

Blood Signature Analysis Helps Diagnose Parkinson’s Disease Earlier

The diagnosis of Parkinson's is usually not established until advanced neurodegeneration leads to clinically detectable symptoms involving the malfunction and death of vital nerve cells in the brain.... Read more

Pathology

view channel
Image: The INNOTEST enzyme-linked immunosorbent assay kits for Alzheimer disease biomarkers (Photo courtesy of Fujirebio-Europe).

Small Molecule Detects Alzheimer's Disease at Early Stages

A high level of a small molecule called D-serine have been identified as associated with cognitive decline in Alzheimer’s disease (AD) and holds the potential to represent a novel and effective biomarker for AD.... Read more

Industry News

view channel

Main Factors Driving Revenue Growth in Clinical Chemistry Identified

According to a report by Kalorama Information (New York, NY, USA), overall growth in the clinical chemistry market will be modest, driven mainly by new tests and demographic changes, including an aging population and increasing number of people at risk of cardiovascular disease, such as those with hypertension, diabetes... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.